SCHEMBL3846579

SCHEMBL3846579

COC(=O)c1ccccc1-c1ccc(-c2ccn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.52
SLC6A4 P31645 3/20 0.52
SLC6A2 P23975 1/20 0.47
BRS3 P32247 2/20 0.44
ALDH1A1 P00352 4/20 0.43
ALDH1A2 O94788 1/20 0.43
ALDH1A3 P47895 1/20 0.43
ROCK2 O75116 1/20 0.40
CSF1R P07333 1/20 0.40
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
CDK5 Q00535 1/20 0.40
ROCK1 Q13464 1/20 0.40
SLK Q9H2G2 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
LTB4R2 Q9NPC1 1/20 0.40
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850285 0.86 ALDH1A1 (0.49) ALDH1A1ALDH1A2ALDH1A3KDM4EMAPT
SCHEMBL13874241 0.82 SLC6A3 (0.60) SLC6A3SLC6A4SLC6A2BRS3ALDH1A1
SCHEMBL3893167 0.81 SLC6A3 (0.52) SLC6A3SLC6A4SLC6A2BRS3ALDH1A1
SCHEMBL5800759 0.77 KMT2A (0.52) ALDH1A1ALDH1A2ALDH1A3KDM4EMAPT
SCHEMBL3846751 0.76 KMT2A (0.44) ALDH1A1ALDH1A3KDM4EMAPTSMN1; SMN2
SCHEMBL3855945 0.76 HDAC1 (0.43) ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL31318316 0.75 SLC6A3 (0.78) SLC6A3SLC6A4SLC6A2ALDH1A1ROCK2
SCHEMBL3852197 0.75 TGFBR1 (0.40) SLC6A3SLC6A4SLC6A2BRS3ALDH1A1
SCHEMBL1775832 0.75 SLC6A3 (0.74) SLC6A3SLC6A4SLC6A2ALDH1A1ROCK2
SCHEMBL3849289 0.74 SLC6A3 (0.41) SLC6A3SLC6A4SLC6A2BRS3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed